Recent News

• 06.16.2025 - June 16, 2025 - June 19, 2025 : 2025 BIO International Convention
• 04.11.2025 - 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.11.2025 - April 11, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.10.2025 - April 10, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 03.12.2025 - Leerink Partners Global Healthcare Conference
• 02.24.2025 - Entera Bio to Participate in Upcoming Events
• 02.24.2025 - Entera Bio to Participate in Upcoming Events
• 02.19.2025 - EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
• 02.19.2025 - EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
• 02.11.2025 - February 11, 2025 12:40 PM EST - February 11, 2025 1:10 PM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference

Recent Filings

• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.10.2025 - 8-K Current report
• 01.06.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors